#32026D0390Commission Implementing Decision (EU) 2026/390 extending Dutch emergency authorisation for indoor use of Vectobac WG biocidal product
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The European Commission has approved the extension of an emergency measure originally taken by the Dutch Ministry of Infrastructure and Water Management. This allows the continued making available on the market and professional use of the biocidal product Vectobac WG (containing Bacillus thuringiensis subsp. israelensis strain AM 65-52) for controlling larvae and adult invasive exotic mosquitoes (such as Aedes albopictus and Aedes aegypti) in indoor locations like ports and airports. The product was previously authorised only for outdoor use in the Netherlands. The extension is justified by ongoing public health risks from mosquito-borne diseases including dengue and yellow fever, and the absence of effective alternatives for indoor control.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Extends the Dutch emergency authorisation of Vectobac WG for indoor use by 550 days until 2 May 2027
- Permits making available on the market and professional use for control of invasive exotic mosquitoes and larvae only in locations where presence has been detected
- Applies retroactively from 29 October 2025 following the expiry of the original measure on 28 October 2025
+ 2 more changes with Pro
Obligations
What this law requires
Extend the emergency authorization for making available on the market and professional use of Vectobac WG for indoor control of invasive exotic mosquitos until 2 May 2027
Ensure Vectobac WG is only used in indoor locations where the presence of invasive exotic mosquitos has been detected
Restrict use of Vectobac WG to professional users only
Limit use of Vectobac WG to indoor locations such as ports and airports where invasive exotic mosquitos are present
Prepare and submit an application for full authorization of Vectobac WG covering indoor use before the 2 May 2027 expiration date to establish a long-term solution